Anglia Capital Group (ACG) is holding a female Angel investing seminar and pitching day at The EpiCentre, near Cambridge, on Friday 27th September 2024, sponsored by the British Business Bank.

Polish pet sitting and pet care startup Petsy has raised more than €1.1 million in funding from business angels.

Compliance-AI startup Falco has been announced as the winner of the South East Angels Kent roadshow.

Founders, investors, and key stakeholders from the Kent startup ecosystem came together in August 2024 for the startup event as part of the Startup Roadshow 2024 series. These events, hosted by South East

WeDonate, a reward platform for blood donors to encourage participation and Bluco, a WhatsApp-based app to make job applications easier, took the two £25,000 top prizes in this year's AXA Startup Angel competition.

COREangelsMEA, a member of COREangels International, has invested in Plain Tiger, an innovative startup transforming the B2B hospitality sector. This investment follows COREangelsMEA's fourth investment committee, held on July 3rd, which attracted over 750 applications from startups across the region. ABAN (African Business Angel Network) contributed as a co-investment partner in this round. 

Morphose Capital Partners, a London-based firm specialising in mergers and acquisitions, corporate restructuring, and finance, has completed an oversubscribed pre-seed funding round for Hospitaliti, an innovative social platform designed to connect the global hospitality industry. 

Evelyn Partners, the professional services group, has teamed up with impact investment platform, Ethical Equity, to support its Aspiring Angel Investor Programme. The comprehensive programme is designed to empower emerging investors and equip them with the knowledge and resources needed to navigate the world of angel investing in early-stage businesses making a positive social impact.

NanoSyrinx, a synthetic biology company developing nanosyringes as a novel platform for targeted intracellular delivery of biologic therapeutics, has closed a c. £10 million (c. $13 million) financing round.

PhoreMost Ltd, a leading UK biopharmaceutical company unlocking the next generation of drug targets, has added USD $12 million to its Series B financing, bringing the total raised to over $50 million. The additional investment was led by Parkwalk Advisors, the largest growth EIS fund manager, with participation from existing investors BGF, Dr Jonathan Milner, Amadeus Capital and Astellas Venture Management, and will support the progression of PhoreMost's pipeline of novel degrader assets.

London-based investment firm Outward VC has reached the first closing of its Fund II at £51 million. The fund has received a cornerstone investment of £30m from the British Business Bank, which is deploying capital through its Enterprise Capital Funds programme, which has a strong track record in backing emerging, UK-based Venture Capital fund managers. A wide range of private investors are also participating in the fund.

SOLASTA Bio, a leading agri-biotech company specialising in the next generation of green insecticides, has completed an oversubscribed $14 million Series A funding round to accelerate the development of its unique peptide-based, nature-inspired bioinsecticides - the first of their kind to be developed worldwide.

The investment round was led by Forbion via its BioEconomy fund strategy, with co-lead investment from agricultural strategics FMC Ventures (FMC Corporation) and Corteva Inc., through its Corteva Catalyst platform. Participation from existing investors included Cavallo Ventures (Wilbur-Ellis), Rubio Impact Ventures, Scottish Enterprise, UKi2S, SIS Ventures and University of Glasgow, bringing the total raised to date to $19 million. In the context of this round Joy Faucher from Forbion will join the company's board of directors.

Optalitix, the specialist finance software provider, has raised US$3million of follow-on funding, led by existing investor Calculus Capital, with participation from 24 Haymarket and others. The latest successful funding brings the total capital raised by the company to US$8m.

The funding proceeds will be used to further accelerate product innovation and support the execution of Optalitix’s ambitious expansion plans.